Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Genvoya

02 5Stribild

PharmaCompass

01

Brand Name : Stribild

Elvitegravir

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Stribild

arrow
Medlab Asia & Asia Health
Not Confirmed

Elvitegravir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 196

2019 Revenue in Millions : 369

Growth (%) : -47

blank

02

Brand Name : Genvoya

Elvitegravir

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Genvoya

arrow
Medlab Asia & Asia Health
Not Confirmed

Elvitegravir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 3,338

2019 Revenue in Millions : 3,931

Growth (%) : -15

blank

03

Brand Name : Stribild

Elvitegravir

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Stribild

arrow
Medlab Asia & Asia Health
Not Confirmed

Elvitegravir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 189

2020 Revenue in Millions : 196

Growth (%) : -4

blank

04

Brand Name : Genvoya

Elvitegravir

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Genvoya

arrow
Medlab Asia & Asia Health
Not Confirmed

Elvitegravir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 2,879

2020 Revenue in Millions : 3,338

Growth (%) : -14

blank

05

Brand Name : Stribild

Elvitegravir

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Stribild

arrow
Medlab Asia & Asia Health
Not Confirmed

Elvitegravir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2022 Revenue in Millions : 127

2021 Revenue in Millions : 189

Growth (%) : -33

blank

06

Brand Name : Genvoya

Elvitegravir

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Genvoya

arrow
Medlab Asia & Asia Health
Not Confirmed

Elvitegravir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2022 Revenue in Millions : 2,404

2021 Revenue in Millions : 2,879

Growth (%) : -16

blank

07

Brand Name : Genvoya

Elvitegravir

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Genvoya

arrow
Medlab Asia & Asia Health
Not Confirmed

Elvitegravir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2023 Revenue in Millions : 2,060

2022 Revenue in Millions : 2,404

Growth (%) : -14

blank

08

Brand Name : Stribild

Elvitegravir

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Stribild

arrow
Medlab Asia & Asia Health
Not Confirmed

Elvitegravir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2023 Revenue in Millions : 101

2022 Revenue in Millions : 127

Growth (%) : -20

blank

09

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Genvoya

arrow
Medlab Asia & Asia Health
Not Confirmed

Elvitegravir, Cobicistat, Emtricitabine, Tenofovir alaf...

Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

Currency : USD

2015 Revenue in Millions : 0

2014 Revenue in Millions : 45

Growth (%) : New Launch

blank

10

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Genvoya

arrow
Medlab Asia & Asia Health
Not Confirmed

Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alaf...

Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

Currency : USD

2017 Revenue in Millions : 3,674

2016 Revenue in Millions : 1,484

Growth (%) : 148

blank